Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/981| Title: | The National Prescribing Service should lead. |
| Epworth Authors: | Stockigt, Jim R. |
| Keywords: | PI Pharmaceutical Industry Therapeutic Goods Administration TGA Drug Information Product Information Obstetrics and Gynaecology Clinical Institute, Epworth HealthCare, Victoria, Australia Department of Endocrinology and Diabetes, Epworth HealthCare, Victoria, Australia UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia |
| Issue Date: | May-2007 |
| Publisher: | Australasian Medical Publishing Company |
| Citation: | Med J Aust. 2007 May 7;186(9):484. |
| Abstract: | In reply: It is encouraging that Donohoo, on behalf of MIMS, supports initiatives to more regularly update product information (PI). My review1 demonstrates that necessity. The material published by MIMS is apparently not under their direct editorial control; it depends on PI from the pharmaceutical industry, vetted by the Therapeutic Goods Administration. |
| URI: | http://hdl.handle.net/11434/981 |
| PubMed URL: | https://www.ncbi.nlm.nih.gov/pubmed/17484717 |
| ISSN: | 0025-729X 1326-5377 |
| Journal Title: | Medical Journal of Australia |
| Type: | Letter |
| Affiliated Organisations: | Monash University, Melbourne, VIC. |
| Type of Clinical Study or Trial: | Cohort Study |
| Appears in Collections: | Health Administration |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.